FDA approves Click’s digital therapeutic for episodic migraine
More than 37 million adults in the US are affected by migraine The US Food and Drug Administration (FDA) has...
adminph
Aidan Synnott
Oncodesign Services has appointed Aidan Synnott as CEO Oncodesign Services has announced the appointment of Aidan Synnott as its new...
Popular diabetes medications, including GLP-1 drugs, may protect against Alzheimer's disease
A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular...
Leqembi approved as first treatment to slow early Alzheimer’s progression
European Commission grants authorisation for Eisai and Biogen therapy The European Commission has granted marketing authorisation for Leqembi (lecanemab), making...
Pepaxti shows effectiveness in heavily pretreated multiple myeloma patients
New real-world data reinforce treatment benefit Real-world data from the University of Catania, Italy, suggest that Pepaxti, a treatment for...
Potential treatment for Parkinson's using investigational cell therapy shows early promise
A stem cell-based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for...
Researchers develop an LSD analogue with potential for treating schizophrenia
University of California, Davis researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic...
New data reinforce daratumumab as standard of care for multiple myeloma
Long-term survival projections suggest improved outcomes for patients New data from Janssen-Cilag International NV suggest that subcutaneous DARZALEX (daratumumab) quadruplet...
Global data highlights effectiveness of romosozumab
Studies show improved bone mineral density and healthcare cost reductions New data from multiple countries confirm the effectiveness of romosozumab,...
UK clinical trials regulations signed into law
Major update aims to accelerate research and strengthen patient safety New UK clinical trials regulations have been signed into law,...
New test prototype for monitoring MGUS patients funded
Birmingham researchers to make MGUS monitoring more efficient Birmingham researchers have received £230k from Cancer Research Horizons to develop a...
The gut health benefits of sauerkraut
Is sauerkraut more than just a tangy topping? A new University of California, Davis, study published in Applied and Environmental...
Potential Alzheimer's disease therapeutic target identified in brain immune cells
Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its...
First treatment for common bladder cancer recommended by NICE
Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration Balversa (erdafitinib)...
Lab-grown lung cancer cells show potential to revolutionise treatment
The model could lead to more targeted treatments for the disease Cancer Research scientists have developed a new cell-based model...
New study reveals how tumors hijack key nutrient to evade immune attack
Chinese scientists have revealed a hidden metabolic partnership between breast cancer cells and immune cells that drives aggressive tumor behavior...
NHS launches spring COVID-19 booster campaign
An estimated 7.5 million people will be invited to receive the booster The NHS has started delivering its spring COVID-19...
SkyCell and Microsoft partner to improve pharma supply chains
AI-powered SkyMind is designed to improve efficiency, compliance and decision-making SkyCell has partnered with Microsoft to launch SkyMind, an artificial...
Alternative approach to Lyme disease vaccine development shows promise in pre-clinical models
Meeting the unmet need for a vaccine is the top priority for researchers studying Lyme disease, which infects about 476,000...
MHRA approves prostate cancer imaging agent trofolastat
Approximately 55,100 new cases of prostate cancer are diagnosed every year in the UK The Medicines and Healthcare products Regulatory...
